News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Drugmakers: Moratorium On Advertising New Drugs
June 20, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
June 16, 2008 - Pharmalot -- Responding to pressure from Congress, Merck, Schering-Plough, Johnson & Johnson and Pfizer agreed to a six-month moratorium on DTC ads for new drugs and will limit how docs are used in their ads.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Johnson & Johnson Family of Companies
Merck & Co.
Pfizer
MORE ON THIS TOPIC
Complete response letters
FDA freezes CRL trove as ‘radical transparency’ push hits speedbump
July 9, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Amgen recalls almost 1 million bottles of heart failure drug over quality issue
July 8, 2026
·
1 min read
·
Nick Paul Taylor
Podcast
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
July 8, 2026
·
1 min read
·
Jef Akst
Approvals
Vera moves into growing kidney disease space with FDA’s accelerated IgAN nod
July 7, 2026
·
2 min read
·
Annalee Armstrong